Joseph Boland (National Cancer Institute, Gaithersburg Maryland USA) using a prior technique and sequencing platform was able to only obtain 70% sequencing coverage. Find out how much better coverage they had in switching over to Ion Torrent sequencing for their research.
If you have a particular research application, an Ion AmpliSeq™ Custom Panel may meet your needs.
From tumor heterogeneity to low-frequency variants: How qPCR, dPCR, and NGS work together in cancer research
Dr. Javier Hernandez Losa explains how combining broad genom... Deepak Tripathi, PhD
Read More
A scalable multiplex miRNA profiling workflow for precision oncology research
The promise of precision oncology rests on our ability to re... Deepak Tripathi, PhD
Read More
Improving the Reliability of Liquid Biopsy in Real-World Settings Through Workflow Standardization: A Discussion with Dr. Matteo Allegretti
Liquid biopsy offers a powerful, noninvasive way to detect a... Deepak Tripathi, PhD
Read More
Optimizing multiplex qPCR: How to amplify up to 6 targets without compromising analytical sensitivity
What happens when a multiplex qPCR assay begins to lose perf...
Read More
Leave a Reply